Investors & Media

SEC Filing Details

Investor Relations Menu
Financials & Filings
Investor Contact

Adam Levy
Senior Vice President,
Investor Relations
alevy@zentalis.com

Emily White
Solebury Strategic Communications
ewhite@soleburystrat.com

Media Contact

Julia Deutsch
Solebury Strategic Communications
jdeutsch@soleburystrat.com

Document Details

Form
Filing Date
Apr 11, 2022
Document Date
Apr 8, 2022
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
Zentalis Pharmaceuticals
Issuer
ZENTALIS PHARMACEUTICALS, INC.